cannabis indica

Índice completo — página 60 de 77

Estudos 5.901 a 6.000 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2014 a 2013. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 5.901 a 6.000

  1. 2014

    The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome

    InconclusivoMetanáliseSíndrome dos Ovários Policísticos
  2. 2014

    The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study

    FavorávelEnsaio ClínicoDorDor — CrônicaDor — Neuropatia PeriféricaCanabinol (CBN)
  3. 2014

    The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain

    DesfavorávelEnsaio ClínicoDorDor — CrônicaPsicoseTHC Farmacêutico+1
  4. 2014

    Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study

  5. 2014

    Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

    FavorávelEnsaio ClínicoInflamaçãoFibroseHepatiteEndocanabinoide (não especificado)+2
  6. 2014

    TRP Channel Cannabinoid Receptors In Skin Sensation, Homeostasis, And Inflammation

    FavorávelMetanáliseAcneSeborreiaCanabigerol (CBG)Canabicromeno (CBC)
  7. 2014

    TRP channels in lower urinary tract dysfunction

    FavorávelMetanáliseInfecção Urinária
  8. 2014

    Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage.

  9. 2014

    Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — Síndrome de DravetCanabigerol (CBG)
  10. 2014

    Xylanase supplementation of a wheat-based diet improved nutrient digestion and mRNA expression of intestinal nutrient transporters in broiler chickens infected with Clostridium perfringens

    DesfavorávelEstudo em AnimaisInfecções BacterianasProteína Ligadora de Ácidos Graxos (FABP)
  11. 2014

    β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.

    FavorávelEstudo em AnimaisDoença de AlzheimerCanabinoides Sintéticos AM-x
  12. 2014

    β-Caryophyllene, A CB2 Receptor Agonist Produces Multiple Behavioral Changes Relevant To Anxiety And Depression In Mice

    FavorávelEstudo em AnimaisAnsiedadeDepressãoTOCCanabinoides Sintéticos AM-x
  13. 2014

    γ-Terpineol Inhibits Cell Growth and Induces Apoptosis in Human Liver Cancer BEL-7402 Cells in Vitro

    FavorávelEstudo LaboratorialCâncerCâncer — Fígado
  14. 2014

    Δ9-tetrahydrocannabinol Prevents Methamphetamine-induced Neurotoxicity

  15. 2013

    "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report

  16. 2013

    2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.

  17. 2013

    3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis

    FavorávelEstudo em AnimaisDorInflamaçãoDepressãoEndocanabinoide (não especificado)+1
  18. 2013

    A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids

  19. 2013

    A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain

    FavorávelEnsaio ClínicoDorCâncerAnsiedadeTHC:CBD Farmacêutico+6
  20. 2013

    A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisDepressão
  21. 2013

    Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury.

    FavorávelEstudo em AnimaisAVCCanabinoides Sintéticos AM-x
  22. 2013

    Acute effects of capsaicin on energy expenditure and fat oxidation in negative energy balance

    FavorávelEnsaio ClínicoEstresse OxidativoObesidadeDietaCapsaicina (CAPS)
  23. 2013

    Acute Effects of THC on Time Perception in Frequent and Infrequent Cannabis Users

    InconclusivoEnsaio Clínico Duplo-CegoDisfunção CognitivaLibidoDisfunção Erétil
  24. 2013

    Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis

  25. 2013

    Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings

  26. 2013

    Addition of capsaicin and exchange of carbohydrate with protein counteract energy intake restriction effects on fullness and energy expenditure

  27. 2013

    AKI Associated with Synthetic Cannabinoids: A Case Series

  28. 2013

    Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment

  29. 2013

    Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease

    FavorávelEstudo LaboratorialDoença CelíacaAnandamida (AEA)
  30. 2013

    An accidental fatal intoxication with methoxetamine

  31. 2013

    An ultra-low dose of tetrahydrocannabinol provides cardioprotection.

  32. 2013

    Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile

  33. 2013

    Anandamide deficiency and heightened neuropathic pain in aged mice

    FavorávelEstudo em AnimaisDorDor — Neuropatia PeriféricaAnandamida (AEA)
  34. 2013

    Anandamide transforms noncopulating rats into sexually active animals

    FavorávelEstudo em AnimaisLibidoDisfunção ErétilAnandamida (AEA)
  35. 2013

    Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors.

    FavorávelEstudo em AnimaisDermatite de Contato AlérgicaTetraidrocanabinol (THC)
  36. 2013

    Anticancer activity of anandamide in human cutaneous melanoma cells

    FavorávelEstudo LaboratorialCâncerCâncer — MelanomaAnandamida (AEA)
  37. 2013

    Anticancer and antioxidant properties of terpinolene in rat brain cells

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  38. 2013

    Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil

    FavorávelEstudo LaboratorialInflamaçãoEstresse Oxidativo
  39. 2013

    Antinociceptive Activity and Redox Profile of the Monoterpenes (+)-Camphene, p-Cymene, and Geranyl Acetate in Experimental Models.

    FavorávelEstudo em AnimaisDorDor — Polineuropatia Inflamatória
  40. 2013

    Antinociceptive and Antioxidant Activities of Phytol In Vivo and In Vitro Models.

    FavorávelEstudo em AnimaisDorEstresse OxidativoDor — Polineuropatia Inflamatória
  41. 2013

    Antioxidant effects of nerolidol in mice hippocampus after open field test.

    FavorávelEstudo em AnimaisAnsiedadeEstresse OxidativoDoenças Neurodegenerativas
  42. 2013

    Antioxidative properties and inhibition of key enzymes relevant to type-2 diabetes and hypertension by essential oils from black pepper

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)DiabetesHipertensão Arterial
  43. 2013

    Around‐the‐clock oral THC effects on sleep in male chronic daily cannabis smokers.

  44. 2013

    Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors

  45. 2013

    Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists.

    FavorávelEstudo LaboratorialHIV/AIDSCanabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x+2
  46. 2013

    Bioactive lipid mediators in skin inflammation and immunity

  47. 2013

    Borneol, a bicyclic monoterpene alcohol, reduces nociceptive behavior and inflammatory response in mice

    FavorávelEstudo em AnimaisInflamação
  48. 2013

    Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice

    FavorávelEstudo em AnimaisDoença de ParkinsonDistoniaCoreia
  49. 2013

    Cannabidiol Enhances Consolidation Of Explicit Fear Extinction In Humans

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeHemorroidas
  50. 2013

    Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

    FavorávelMetanáliseInflamaçãoDoenças NeurodegenerativasDoença de Parkinson+2
  51. 2013

    Cannabidiol in inflammatory bowel diseases: a brief overview.

  52. 2013

    Cannabidiol Reduces Cigarette Consumption In Tobacco Smokers: Preliminary Findings

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Nicotina
  53. 2013

    Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.

  54. 2013

    Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression

    FavorávelEstudo LaboratorialEpilepsiaCanabidivarina (CBDV)
  55. 2013

    Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

  56. 2013

    Cannabinoid Hyper-emesis Syndrome: An Enigma

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  57. 2013

    Cannabinoid Hyperemesis Syndrome

  58. 2013

    Cannabinoid Hyperemesis Syndrome

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  59. 2013

    Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells

    FavorávelEstudo LaboratorialCâncerCâncer — EstômagoCanabinoides Sintéticos WIN-x
  60. 2013

    Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.

    InconclusivoEstudo em AnimaisAnsiedadeDepressãoEsquizofreniaCanabinoides Sintéticos CP-x
  61. 2013

    Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.

    FavorávelEstudo LaboratorialDoença de HuntingtonAnandamida (AEA)Outros Compostos Relacionados
  62. 2013

    Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an in vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction

  63. 2013

    Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury.

  64. 2013

    Cannabis and the Lung: No More Smoking Gun?

    DesfavorávelMetanáliseCâncerCâncer — PulmãoDPOC
  65. 2013

    Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report

    FavorávelMetanáliseTHC:CBD Farmacêutico
  66. 2013

    Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation

    FavorávelMetanáliseCâncerCâncer — Leucemia
  67. 2013

    Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study

  68. 2013

    Cannabis use and impairment of respiratory function

    DesfavorávelMetanáliseBronquite
  69. 2013

    Cannabis use and suicidal ideation

    InconclusivoMetanáliseTentativa de Suicídio
  70. 2013

    Cannabis-induced acute pancreatitis

    DesfavorávelMetanálisePancreatite
  71. 2013

    Cannabis: a rare cause of acute pancreatitis

    DesfavorávelMetanálisePancreatite
  72. 2013

    Cardioprotective Effect of Cannabidiol in Rats Exposed to Doxorubicin Toxicity

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Infarto
  73. 2013

    Cardiovascular effects induced by α-terpineol in hypertensive rats

  74. 2013

    CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release.

    FavorávelEstudo em AnimaisDiabetesAnandamida (AEA)Endocanabinoide (não especificado)+7
  75. 2013

    Characterization of Anxiolytic and Neuropharmacological Activities of Silexan

    FavorávelEstudo em AnimaisAnsiedadeInsônia e Distúrbios do Sono
  76. 2013

    Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men

    FavorávelEnsaio ClínicoObesidadeÔmega-3
  77. 2013

    Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists

    FavorávelEstudo LaboratorialCâncerCâncer — PâncreasCanabinoide Sintético (não especificado)
  78. 2013

    Composition and in vitro anticancer activities of the leaf essential oil of Neolitsea variabillima from Taiwan.

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoCâncer — Cólon+4
  79. 2013

    Compulsive showering and marijuana use – the cannabis hyperemisis syndrome

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  80. 2013

    COX-2 And PPAR-γ Confer Cannabidiol-induced Apoptosis Of Human Lung Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  81. 2013

    Critical Appraisal Of The Potential Use Of Cannabinoids In Cancer Management

  82. 2013

    Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

  83. 2013

    Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro

    FavorávelEstudo em AnimaisFibroseFibrose — Hepática (Cirrose)Cúrcuma
  84. 2013

    Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção CognitivaPsicoseTetraidrocanabinol (THC)+3
  85. 2013

    Delta 9-THC is protective through PPAR gamma dependent mitochondrial biogenesis in a cell culture model of Parkinson’s disease

    FavorávelEstudo LaboratorialDoença de ParkinsonTetraidrocanabinol (THC)
  86. 2013

    Driving under the influence of synthetic cannabinoids ("Spice"): a case series

  87. 2013

    Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis

  88. 2013

    Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake

  89. 2013

    Effect of borneol on cytochrome P450 3A enzyme and midazolam pharmacokinetics in rats

    InconclusivoEstudo em Animais
  90. 2013

    Effect of diet on tissue levels of palmitoylethanolamide

  91. 2013

    Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

    InconclusivoEnsaio Clínico Duplo-CegoDorInflamaçãoDor — CrônicaTHC Farmacêutico+3
  92. 2013

    Effectiveness of palmitoylethanolamide on endothelial dysfunction in ocular hypertensive patients: a randomized, placebo-controlled cross-over study

  93. 2013

    Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs

    FavorávelEstudo em AnimaisDorCâncerPsicoseTHC Farmacêutico+11
  94. 2013

    Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats.

    FavorávelEstudo em AnimaisInsônia e Distúrbios do Sono
  95. 2013

    Effects of marijuana smoking on the lung

    InconclusivoMetanáliseCâncerEfeitos Adversos da CannabisCâncer — Pulmão+1
  96. 2013

    Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Agonist Rimonabant on Satiety Signaling in Overweight People with Schizophrenia

  97. 2013

    Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial

    FavorávelEnsaio Clínico Duplo-CegoTosseBronquite
  98. 2013

    Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum

    FavorávelEstudo em AnimaisArtriteArtrite — OsteoartriteAcupuntura (MTC)
  99. 2013

    Elevated anandamide and related N-acylethanolamine levels occur in the peripheral blood of women with ectopic pregnancy and are mirrored by changes in peripheral fatty acid amide hydrolase activity

  100. 2013

    Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study